CELG News and Press, Celgene Corporation From 05/03/19

After Geron's ( GERN ) stock price experienced a meteoric rise and equally spectacular fall in the second half of 2018, it appears as though the stock might finally be about to stabilize. After reaching an intra-day high of $6.99 (market cap of $1.29B) on 09/13/18, Johnson & Johnson-owned ...

Read more ...

Bristol-Myers Squibb (NYSE: BMY ) upgraded to Overweight with a $55 (17% upside) price target at Barclays. Shares up  1%  premarket. More news on: Bristol-Myers Squibb Company, Acceleron Pharma Inc., Incyte Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Celgene Corporation (Nasdaq: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the New England Journal of Medicine (NEJM) has published interim results from CRB-401, the ongoing phase 1 study of bb2121, the companies’ lead investigational BCMA-targeted chimeric antige...

Read more ...

Read more ...

The first patient has been dosed in a Phase 3 clinical trial in Taiwan evaluating MorphoSys AG's ( MOR ) CD38-targeting antibody TJ202/MOR202, combined with Celgene's ( CELG ) Revlimid (lenalidomide), in patients with relapsed/refractory multiple myeloma. More news on: MorphoSys AG, Celg...

Introduction It's not the best portent when AbbVie ( ABBV ) beats and raises , yet still gets a muted response as happened last week. With the 10-Q not out yet, and "risa" - now Skyrizi - on the market, that led me to read through the 10-K and read the Q1 conference call which I had lis...

Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...

Portola Pharmaceuticals ( PTLA ) - The company announced that the European Commission granted conditional Marketing Authorization for Ondexxya (andexanet alfa) to be used in adult patients treated with the Factor Xa inhibitor apixaban or rivaroxaban when reversal of anticoagulation is needed...